publication venue for Eradication of LIG4-deficient glioblastoma cells by the combination of PARP inhibitor and alkylating agent.. 9:36867-36877. 2018 V-ATPase-dependent repression of androgen receptor in prostate cancer cells.. 9:28921-28934. 2018 Silencing ROR1 and ROR2 inhibits invasion and adhesion in an organotypic model of ovarian cancer metastasis.. 8:112727-112738. 2017 Methionine restriction on oxidative stress and immune response in dss-induced colitis mice.. 8:44511-44520. 2017 S-nitrosation on zinc finger motif of PARP-1 as a mechanism of DNA repair inhibition by arsenite.. 7:80482-80492. 2016 The degree of intratumor mutational heterogeneity varies by primary tumor sub-site.. 7:27185-27198. 2016 ----Cyclic AMP efflux inhibitors as potential therapeutic agents for leukemia.. :-. 2016 A targeted genetic association study of epithelial ovarian cancer susceptibility.. 7:7381-7389. 2016 Targeting the ROR1 and ROR2 receptors in epithelial ovarian cancer inhibits cell migration and invasion.. 6:40310-40326. 2015 Targeted or whole genome sequencing of formalin fixed tissue samples: potential applications in cancer genomics.. 6:25943-25961. 2015 Anti-G-CSF treatment induces protective tumor immunity in mouse colon cancer by promoting protective NK cell, macrophage and T cell responses.. :-. 2015 Targeting of mutant p53-induced FoxM1 with thiostrepton induces cytotoxicity and enhances carboplatin sensitivity in cancer cells.. 5:11365-11380. 2014
